SHENZHEN XINHENGYUN TECHNOLOGY CO., LTD. – Trademark Portfolio

Entity Type: 99

SHENZHEN XINHENGYUN TECHNOLOGY CO., LTD. holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 1 filings in this category. Currently, 1 trademark is registered. Notable registered marks include HOMULTUIN. The owner is based in SHENZHEN.

801, DACHENG TIMES BLDG., XIAZAO

VILLAGE, COMPREHENSIVE BLDG.A, GAOFENG COMMUNITY,, DALANG ST., LONGHUA DIST.,

SHENZHEN 518109 , CN

1 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

HOMULTUIN
HOMULTUIN
Registered 2021

Trademark Classifications

SHENZHEN XINHENGYUN TECHNOLOGY CO., LTD.'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

10
Medical Apparatus (1 filing)

Surgical, medical, dental and veterinary apparatus and instruments

Frequently Asked Questions

How many trademarks does SHENZHEN XINHENGYUN TECHNOLOGY CO., LTD. have?

SHENZHEN XINHENGYUN TECHNOLOGY CO., LTD. has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.

What trademark classes does SHENZHEN XINHENGYUN TECHNOLOGY CO., LTD. file in?

SHENZHEN XINHENGYUN TECHNOLOGY CO., LTD. files trademarks across 1 Nice Classification class. The most active classes are Class 10 (Medical Apparatus). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.

What are SHENZHEN XINHENGYUN TECHNOLOGY CO., LTD.'s most well-known trademarks?

SHENZHEN XINHENGYUN TECHNOLOGY CO., LTD.'s registered trademark portfolio includes well-known marks such as HOMULTUIN. These are among 1 currently registered trademark in the portfolio.

What is SHENZHEN XINHENGYUN TECHNOLOGY CO., LTD.'s trademark registration success rate?

SHENZHEN XINHENGYUN TECHNOLOGY CO., LTD. has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.